Central Nervous System (CNS)

Working together for health.

Developing therapies for central nervous system issues take dedicated care and specific understanding. For projects involving neurology, psychiatry, or neuroimaging, our decades of work in this field mean we can develop strategic and practical support that simplifies your journey. So whether you’re working in Alzheimer’s, Parkinson’s, Sleep disorders, Schizophrenia, Addiction, or another area, Parexel's global teams are committed to helping make life easier for you and the people you aim to help.

Strengths of our Central Nervous System (CNS) team include:
  • Strategic insight into design and development of CNS trials. We have expertise incorporating state-of-the-art biomarkers and other approaches from our CNS Toolkit, diagnostic adjudication approaches to ensure randomization of appropriate patients, and enhanced signal detection strategies to improve clinical trials sensitivity to drug, while reducing sample size
  • Seamless, end-to-end support of CNS drug development from hospital-based First in Human studies to Proof of Concept, Phase III, and post-marketing study commitments. We use “learn and confirm” approaches with the same team members to ensure continuity across all phases of development
  • Demonstrated ability to manage complex central nervous system (CNS) trials in Phase I-IV in every region — North America, Latin America, Europe, Asia, and Australia
  • Extensive work with medical feasibility studies, providing critical data about regions, countries, sites, investigators, standards/quality of care, and competing trials
  • Active engagement in medical education and ongoing clinical care of patients
  • Major commitment to internal CNS training for our staff
  • Experience in academic medicine, hospital-based clinical practice, and clinical and laboratory research investigations

We are always available for a conversation.